The Current Ratio as of November 2024 (TTM) for Celyad Oncology SA (CYAD) is 1.42

According to Celyad Oncology SA’s latest financial reports and current stock price. The company's current Current Ratio is 1.42. This represents a change of -94.02% compared to the average of 23.78 of the last 4 quarters.

Celyad Oncology SA (CYAD) Historical Current Ratio (quarterly & annually)

How has CYAD Current Ratio performed in the past?

The mean historical Current Ratio of Celyad Oncology SA over the last ten years is 4.83. The current 1.42 Current Ratio has changed 2.84% with respect to the historical average. Over the past ten years (40 quarters), CYAD's Current Ratio was at its highest in in the December 2022 quarter at 90.84. The Current Ratio was at its lowest in in the September 2020 quarter at 0.

Celyad Oncology SA (CYAD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Celyad Oncology SA Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Celyad Oncology SA (CYAD) Average Current Ratio

How has CYAD Current Ratio performed in the past?

The current Current Ratio of Celyad Oncology SA (CYAD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Celyad Oncology SA (CYAD) Current Ratio vs. Peers

How is CYAD’s Current Ratio compared to its peers?

Celyad Oncology SA’s Current Ratio is less than Innate Pharma S.A. (2.92), less than Addex Therapeutics Ltd (4.97), greater than Aptorum Group Limited (1.18), less than Dyadic International, Inc. (5.39), less than PMV Pharmaceuticals, Inc. (19.22), less than Eliem Therapeutics, Inc. (60.41), less than MediciNova, Inc. (18.24), less than Pharvaris N.V. (18.45), less than PepGen Inc. (7.45), less than Pasithea Therapeutics Corp. (0), less than Nutriband Inc. (6.20), less than ZIVO Bioscience, Inc. (6.57), greater than null (0.17),

Build a custom stock screener for Celyad Oncology SA (CYAD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celyad Oncology SA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Celyad Oncology SA (CYAD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Celyad Oncology SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.